TwelveStone Health Partners provides Remicade® Infusion Treatment for patients managing autoimmune conditions such as Crohn’s disease, ulcerative colitis, and rheumatoid arthritis. Our experienced clinical team delivers infusion therapy in specialized outpatient centers designed for safety, comfort, and coordinated care.

We offer convenient access through over 30 infusion centers across the Southeast, making it easier to receive ongoing treatment close to home. Our private suites include recliners, WiFi, and refreshments, providing a comfortable alternative to hospital-based care.

Contact our team today to verify your insurance coverage and schedule your Remicade® infusion treatment, or complete our patient referral form to get started.

Medication vial with syringe used for infusion treatment

What to Expect from Remicade (Infliximab) Therapy

Remicade (infliximab) is an intravenous biologic medication used to treat autoimmune and inflammatory diseases by targeting tumor necrosis factor alpha. 

This protein triggers the systemic inflammation that leads to tissue damage and chronic pain in many chronic conditions. While your specialist determines if Remicade® Infusion Treatment is the appropriate choice, it is a primary option for several diagnoses:

  • Crohn’s disease and ulcerative colitis
  • Rheumatoid arthritis
  • Psoriatic arthritis and plaque psoriasis
  • Ankylosing spondylitis

Administration follows a clinical cadence designed to reach and maintain therapeutic levels of the medication. You will typically begin with a series of three loading doses given at weeks zero, two, and six. 

After this initial phase, most patients move to a maintenance schedule with one infusion every six to eight weeks. Your physician directs the specific frequency based on your response and laboratory results.

Consistent therapy depends on a center that coordinates with your gastroenterologist or rheumatologist. Our clinical staff manages the logistical details, including order confirmation and documentation for ulcerative colitis and Crohn’s disease treatments. 

Contact TwelveStone Health Partners to confirm medication availability and discuss the next steps for your referral.

What to Expect During Your Infusion Visit

Choosing a specialized outpatient center for Remicade® Infusion Treatment provides a calm alternative to a hospital. Because this medication is administered slowly for safety, visits typically last several hours while our nursing team monitors your progress. Our staff manages every aspect of your care within our infusion center to ensure comfort.

  1. Check-in and initial vitals assessment
  2. Professional IV placement by a registered nurse
  3. Monitored medication administration in a private suite
  4. Post-infusion observation for safety
  5. Review of discharge instructions and follow-up

Successful sessions begin with preparation at home. Arriving well-hydrated makes the IV placement process easier for our staff. Wear comfortable layers and clothing with sleeves that allow for easy arm access. You may bring a phone charger or entertainment, and our care team can advise on any ordered pre-medications.

Patients have access to private suites with recliners, WiFi, TV, and refreshments. TwelveStone provides a faith-based environment where patients receive care with dignity. We offer optional support through our company chaplain for those seeking spiritual care during treatment. This personal attention ensures your visit is a restorative experience as we coordinate your progress with your physician.

Clinical Safety and Monitoring Standards

Clinical safety begins with thorough screening conducted by your prescribing specialist before the first Remicade® Infusion Treatment. Your doctor typically orders tuberculosis (TB) testing, hepatitis B screening, and a review of your vaccination history. These baseline labs ensure your immune system is prepared for therapy. This proactive approach minimizes clinical risks before administration begins.

Managing Infusion Reactions

Infusion reactions are categorized by when they occur. Acute reactions happen during administration or within 24 hours, while delayed reactions can appear 1 to 14 days later. Our nurses are trained to identify symptoms like flushing, hives, or joint aches early to ensure patient safety.

If a reaction occurs in the suite, our clinical team follows established protocols to protect your health:

  • The nursing staff slows or stops the infusion immediately.
  • Your prescribing provider is notified of the situation.
  • Medications are administered according to your doctor’s specific orders.
  • You remain under observation by our clinical team.

If medication effectiveness changes over time, your specialist may use therapeutic drug monitoring. By checking trough levels and testing for antibodies, your physician can adjust dosages or intervals based on clinical data. Always contact your TwelveStone care team regarding symptoms between visits. For severe issues like difficulty breathing, seek immediate emergency medical care.

Insurance Coverage and Treatment Options

Remicade® Infusion Treatment costs include the medication price and the facility fees for professional administration. Your total out-of-pocket expense depends on your insurance plan and the prior authorization process. TwelveStone handles benefits verification and prior authorization coordination with your prescriber to secure necessary approvals before your first appointment.

Financial Assistance Programs

Commercial copay savings programs often reduce the medication cost for eligible patients. These programs typically do not apply to infusion administration fees or nursing services. For those who are uninsured or have high deductibles, charitable foundations may provide additional support. TwelveStone coordinators help you navigate these applications so cost does not become a barrier to your care.

Understanding Biosimilars

Many insurance providers now require the use of biosimilars such as Inflectra, Avsola, or Renflexis. Clinical studies indicate there are no meaningful differences in safety or effectiveness compared to the original Remicade® Infusion Treatment. Your physician will monitor your clinical response and can order drug-level or antibody testing if your progress changes.

Maintenance therapy usually follows a six to eight week cadence. With 30 locations across the Southeast, we support patients who need to transfer care between states or cities. Home infusion services are also available for select patients who cannot travel to a physical center. Contact TwelveStone Health Partners to verify your benefits and begin your transition to our care.

Frequently Asked Questions About Remicade Therapy

Remicade is a prescription biologic medication that requires a formal order from a licensed specialist, typically a gastroenterologist or rheumatologist. TwelveStone Health Partners coordinates directly with your provider to obtain necessary clinical documentation and insurance authorizations before your first appointment. This administrative support ensures your treatment plan is fully approved and ready before you arrive at our center.

A typical appointment lasts between two and four hours, though the exact duration depends on your individual response to the medication. The infusion itself usually takes about two hours, but we also include time for initial vitals, IV placement, and a post-treatment observation period. Some patients require a slower administration rate if they have a history of sensitivity or if it is their first time receiving the medication.

Most patients begin with a loading phase consisting of three separate doses administered at weeks zero, two, and six. Once this initial period is complete, you will transition to a maintenance schedule, which typically involves one treatment every six to eight weeks. Your prescribing physician for ulcerative colitis and Crohn’s disease will monitor your symptoms to determine if the frequency needs adjustment based on your clinical progress.

Prioritize hydration by drinking plenty of water the day before and the morning of your appointment to make IV access easier for the nursing staff. We recommend eating a full meal before arriving and wearing comfortable, layered clothing to manage temperature changes in the infusion center. You are welcome to bring a laptop or book for entertainment, and we suggest planning for light activity or rest following your session.

Immediate reactions may include flushing, chest tightness, or itching during the administration, while delayed reactions like joint pain or a rash can appear several days later. If you notice any unusual symptoms after leaving the center, contact our clinical care team immediately so we can update your prescribing physician. Seek emergency medical attention if you experience severe symptoms such as difficulty breathing or swelling of the face and throat.

These medications are FDA-approved biosimilars, meaning they have no clinically meaningful differences in safety or effectiveness compared to the original brand. Your specialist manages these transitions and will continue to monitor your response to ensure the medication remains effective for your condition. While insurance providers often require these versions, clinical data supports their interchangeability, and you should report any perceived changes to your doctor.

Please contact TwelveStone Health Partners to verify your insurance benefits and schedule your next treatment.